Clinical biomarkers of response to antiangiogenic therapy with bevacizumab in glioblastoma
Main Author: | Rafaela Gonçalves Lopes |
---|---|
Other Authors: | Faculdade de Medicina |
Format: | Others |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10216/119832 |
Similar Items
-
Complicações vasculares do bevacizumab - o reverso da medalha
by: Sara Cristina Pereira Santos
Published: (2021) -
Long term survivors of Glioblastoma : Clinical and radiological profile of a portuguese cohort
by: João Pedro Borges Catela dos Reis Sousa
Published: (2021) -
Switch from intravitreal bevacizumab to aflibercept for treatment of diabetic macular edema
by: Fernando Miguel Miranda Nogueira
Published: (2019) -
Targeting HER family in HER2-positive metastatic breast cancer: potential biomarkers and novel targeted therapies
by: Inês de Paula Costa Monteiro
Published: (2019) -
Biomarkers and Schizophrenia
by: Joana Maria Ribeiro da Silva
Published: (2019)